OrthoSensor to Present at the Canaccord Genuity Musculoskeletal Conference
SUNRISE, FL (Mar 14, 2013) – OrthoSensor™, Inc., a leader in intelligent orthopedics, today announced the Company will present at the Canaccord Genuity Musculoskeletal Conference at the Westin Michigan Avenue Hotel in Chicago, IL.
“OrthoSensor is pioneering the category of intelligent orthopedics to address the huge unmet need of joint implant failure,” said Jay Pierce, CEO of OrthoSensor. “The cost to the U.S. healthcare system for hospital charges associated with knee replacement revision procedures is expected to approach $9B in 2015. OrthoSensor’s technology drives solutions for all the stakeholders in orthopedics: surgeons, hospitals, payors and patients. The first of our intraoperative surgical systems has been adopted by dozens of orthopedic centers of excellence since we launched last year. Throughout 2013, we will continue to seize the market opportunity with the anticipated introduction of additional intraoperative devices and registry solutions, while furthering the development and commercialization plans for our intelligent implants.”
Mr. Pierce will present an overview of the Company on Tuesday, March 19, 2013 at 3:20 p.m. CT (4:20 p.m. ET).
About OrthoSensor, Inc.
OrthoSensor, Inc., a leader in Sensor-Assisted Total Knee Arthroplasty develops and commercializes intelligent orthopaedic devices and data services that provide quantitative feedback to surgeons and hospitals. The company’s intelligent orthopaedic devices utilize advanced proprietary sensor and communications technologies, coupled with the company’s innovative software products, to facilitate evidence-based decisions in orthopaedic surgery – with the goal of improving patient outcomes and potentially reducing the cost of treating musculoskeletal disease.
OrthoSensor® and VERASENSE™ are trademarks of OrthoSensor, Inc.
CLICK FOR MORE ORTHOSENSOR ANNOUNCEMENTS